Gurnet Point Capital and Patient Square Capital Acquire Radius Health

June 23, 2022

Gurnet Point Capital and Patient Square Capital completed a take-private acquisition of Radius Health, Inc. in a transaction valued at approximately $890 million (including debt), paying $10.00 per share in cash plus a $1.00 CVR tied to TYMLOS sales. Debt financing was provided by OrbiMed Advisors; following the transaction Radius will be delisted and will remain operating in the Boston, MA and Wayne, PA areas as a privately held biopharmaceutical company focused on bone health and neuro-orphan diseases.

Buyers
Gurnet Point Capital, Patient Square Capital
Targets
Radius Health, Inc.
Sellers
Radius shareholders
Industry
Biotechnology
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.